Browser-side verification
Verify Furosemide
คุณไม่ต้องเชื่อ source.cuvetsmo.com — โค้ดด้านล่างทำงานในเครื่องของคุณ คำนวณ SHA-256 และ verify Ed25519 signature เทียบกับ public key ที่อาจารย์เซ็นต์รับเก็บไว้.
Signatures
0
Version
1
Status
pending
⏳ ยังไม่มี signature
Entry นี้ยังไม่ได้ลงนามโดย key ใดเลย — Phase 0 mirror snapshot ที่รอ Thai translation + faculty signoff. ดูสถานะการ review ที่ หน้า detail
Show the raw inputs (paranoid mode)
Drug JSON
This is exactly what your browser canonicalizes + SHA-256-hashes
{
"slug": "furosemide",
"nameEn": "Furosemide",
"nameTh": "ฟูโรซีไมด์",
"class": "Loop diuretic",
"mechanism": "ยาขับปัสสาวะกลุ่ม loop diuretic ยับยั้ง Na-K-2Cl cotransporter ที่ thick ascending limb ของ loop of Henle ทำให้ขับน้ำและเกลือออกมาก; เป็นยาหลักลดภาวะน้ำท่วมปอด/ช่องท้องใน CHF",
"brandNamesTh": [
"Lasix",
"Frusemide"
],
"indications": [
{
"text": "ลดภาวะคั่งน้ำใน congestive heart failure (น้ำท่วมปอด, ascites, pleural effusion); เป็น 1 ใน 4 ยาหลักของการรักษา CHF ร่วมกับ pimobendan, ACE inhibitor, spironolactone",
"cites": [
"acvim-dmvd",
"merck-diuretics"
]
}
],
"contraindications": [
{
"text": "ระวังในสัตว์ขาดน้ำ, ไตวายเฉียบพลัน, electrolyte imbalance; ทำให้ K+ ต่ำซึ่งเพิ่มพิษ digoxin",
"cites": [
"merck-diuretics"
]
}
],
"sideEffects": [
{
"text": "ขาดน้ำ, hypokalemia, hyponatremia, azotemia (prerenal), ototoxicity เมื่อขนาดสูง; เมื่อขนาด > 8–10 mg/kg/วัน (สุนัข) หรือ ~6 (แมว) ให้สงสัย furosemide resistance",
"cites": [
"merck-diuretics"
]
}
],
"dosages": [
{
"species": "canine",
"indication": "CHF / pulmonary edema",
"route": "PO",
"dose": "1–5 mg/kg PO/IV/SC ทุก 12–24 ชั่วโมง; เฉียบพลัน 2 mg/kg IV ซ้ำได้ 2–4 mg/kg ถ้าไม่ขับปัสสาวะใน 1 ชม.",
"cites": [
"merck-diuretics",
"acvim-dmvd"
]
},
{
"species": "feline",
"indication": "CHF / pulmonary edema",
"route": "PO",
"dose": "1–4 mg/kg PO/IV/SC ทุก 12–24 ชั่วโมง (ใช้ขนาดต่ำกว่าสุนัข)",
"cites": [
"merck-diuretics"
]
}
],
"citations": [
{
"id": "merck-diuretics",
"type": "textbook",
"title": "Diuretics for Use in Animals — MSD/Merck Veterinary Manual",
"year": 2025,
"url": "https://www.merckvetmanual.com/pharmacology/systemic-pharmacotherapeutics-of-the-cardiovascular-system/diuretics-for-use-in-animals",
"note": "Merck cardiovascular pharmacology — diuretic dosing + furosemide resistance. Copyrighted, cited not mirrored.",
"cid": null
},
{
"id": "acvim-dmvd",
"type": "guideline",
"title": "ACVIM Consensus: diagnosis + treatment of myxomatous mitral valve disease in dogs",
"year": 2019,
"url": "https://onlinelibrary.wiley.com/doi/full/10.1111/jvim.15488",
"note": "ACVIM consensus (J Vet Intern Med) — CHF therapy quartet (furosemide + pimobendan + ACEi + spironolactone). Authoritative.",
"cid": null
},
{
"id": "dailymed-furosemide",
"type": "regulatory-database",
"title": "Furosemide — NLM DailyMed (FDA Structured Product Labeling)",
"year": 2025,
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=furosemide",
"note": "Cross-checked source: FDA-approved labeling. Search by name returns relevant product labelings.",
"cid": "74e39546b4d47c1d263307ac24add79a0ad5282ebda1943dd7ba320b36725598"
},
{
"id": "atc-C03CA01",
"type": "guideline",
"title": "ATC C03CA01 — Furosemide",
"year": 2025,
"url": "https://www.whocc.no/atc_ddd_index/?code=C03CA01&showdescription=no",
"note": "Cross-checked source: WHO Collaborating Centre ATC/DDD index. Authoritative drug classification.",
"cid": "7cc90d8f5d887ec951e04520dea725fedba87e90fe3314da1b8a0d2516336ae7"
},
{
"id": "pubchem-furosemide",
"type": "monograph",
"title": "Furosemide — PubChem search",
"year": 2025,
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Furosemide",
"note": "Cross-checked source: chemical structure, identifiers, pharmacology summary. Faculty review fills exact CID.",
"cid": "c1e8a3643c5c94da8208b334f9fa0b0f989475a6f1374d3a1670480ffad9de6f"
},
{
"id": "who-eml-22",
"type": "guideline",
"title": "WHO Model List of Essential Medicines (22nd List, 2021)",
"year": 2021,
"url": "https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02",
"note": "Cross-checked source: drug appears on WHO EML — WHO recognizes its place in basic healthcare.",
"cid": "71030c795c4e0c0cff56566bfc9ae4ed448eab9188ae68ce773a50d9f7fc53eb"
}
],
"mirroredFrom": [
{
"id": "dailymed",
"name": "NLM DailyMed",
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=furosemide",
"asOfDate": "2026-05-27",
"license": "U.S. Government work — public domain. Attribution recommended."
},
{
"id": "atc",
"name": "WHO ATC Classification",
"url": "https://www.whocc.no/atc_ddd_index/?code=C03CA01&showdescription=no",
"asOfDate": "2026-05-27",
"license": "WHO publication, free for use with attribution"
},
{
"id": "pubchem",
"name": "PubChem (NIH/NLM)",
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Furosemide",
"asOfDate": "2026-05-27",
"license": "NIH/NLM public domain"
},
{
"id": "who-eml",
"name": "WHO Model List of Essential Medicines (22nd List, 2021)",
"url": "https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02",
"asOfDate": "2026-05-27",
"license": "CC BY-NC-SA 3.0 IGO"
}
],
"mirrorCIDs": [
{
"sourceId": "dailymed",
"cid": "74e39546b4d47c1d263307ac24add79a0ad5282ebda1943dd7ba320b36725598",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "atc",
"cid": "7cc90d8f5d887ec951e04520dea725fedba87e90fe3314da1b8a0d2516336ae7",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "pubchem",
"cid": "c1e8a3643c5c94da8208b334f9fa0b0f989475a6f1374d3a1670480ffad9de6f",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "who-eml",
"cid": "71030c795c4e0c0cff56566bfc9ae4ed448eab9188ae68ce773a50d9f7fc53eb",
"capturedAt": "2026-05-27",
"status": "stub"
}
],
"codes": {
"atc": {
"code": "C03CA01",
"name": "Furosemide",
"level": 5
},
"rxnorm": {
"cui": "4603",
"name": "Furosemide"
}
},
"drafting": {
"aiAssisted": false,
"aiModel": null,
"aiPromptHash": null,
"humanReviewer": "palmzamak2547",
"humanReviewedAt": "2026-05-27",
"humanEditsRatio": null
},
"signatures": [],
"reviewedBy": null,
"lastUpdated": "2026-05-27",
"version": 1,
"changelog": [
{
"version": 0,
"date": "2026-05-27",
"summary": "Seed entry — cross-checked from 4 authoritative sources (NLM DailyMed, WHO ATC Classification, PubChem (NIH/NLM), WHO Model List of Essential Medicines (22nd List, 2021)). ATC C03CA01 + RxNorm 4603. Thai translation + faculty review pending."
},
{
"version": 1,
"date": "2026-05-27",
"summary": "Clinical content compiled from cited sources — furosemide 1–5 mg/kg + acute 2 mg/kg IV + resistance threshold verified against Merck diuretics + ACVIM DMVD consensus. Every statement cited. Reviewed by palmzamak2547. Pending faculty canonical signature."
}
],
"monitoring": [
{
"text": "ตรวจ electrolyte (โดยเฉพาะ K+), ค่าไต, และภาวะน้ำในร่างกายเป็นระยะ; K+ ต่ำเพิ่มความเสี่ยงพิษ digoxin",
"cites": [
"merck-diuretics"
]
}
]
}Public keys used
[]